aluates Reports

$ 0.0

Automative

Diabetic Lancet Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: September 2025

Report Code: QYRE-Auto-26B15353

Global Diabetic Lancet Device Market Research Report 2023

BUY CHAPTERS

Diabetic Lancet Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-26B15353

Report

September 2025

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

LifeScan Inc

Abbott

Ascensia

B. Braun

Terumo

Sinocare

Arkray

Bionime

Yuwell

Diabetic Lancet Device- Market Size

The global market for Diabetic Lancet Device was estimated to be worth US$ 323 million in 2024 and is forecast to a readjusted size of US$ 409 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.

Diabetic Lancet Device- Market

A diabetes blood sampling device is a medical instrument used by diabetic patients for blood glucose monitoring.

A diabetes blood sampling device is an essential medical tool for individuals living with diabetes. This device comprises several key components, including a lancet, a glucose meter, test strips, a lancet device, and a logbook. The lancet is a fine needle used to puncture the skin, allowing for the collection of a small blood sample. This sample is then placed on a test strip, which contains specialized chemicals for glucose detection. The test strip is inserted into a glucose meter, an electronic device that measures the blood glucose level and displays the result in numerical form. To ensure a relatively painless and effective blood sampling process, the lancet device"s depth can be adjusted. Patients often use a logbook to record their blood glucose levels, diet, physical activity, and medication intake, providing a comprehensive picture of their diabetes management. Regular blood glucose monitoring with these devices is crucial for maintaining blood sugar levels within the target range and facilitating effective diabetes management. With ongoing advancements, more intelligent and user-friendly blood glucose monitoring solutions continue to emerge, enhancing the convenience and accuracy of diabetes care.

This report aims to provide a comprehensive presentation of the global market for Diabetic Lancet Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetic Lancet Device by region & country, by Type, and by Application.

The Diabetic Lancet Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Lancet Device.

Market Segmentation

Scope of Diabetic Lancet Device- Market Report

Report Metric	Details
Report Name	Diabetic Lancet Device- Market
Forecasted market size in 2031	US$ 409 million
CAGR	3.5%
Forecasted years	2025 - 2031
Segment by Type	50 Test Strips 100 Test Strips 150 Test Strips 200 Test Strips
Segment by Application	Hospitals and Clinics Household Use
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, BIONIME, Yuwell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetic Lancet Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diabetic Lancet Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diabetic Lancet Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Diabetic Lancet Device- Market size in 2031?

Ans: The Diabetic Lancet Device- Market size in 2031 will be US$ 409 million.

Who are the main players in the Diabetic Lancet Device- Market report?

Ans: The main players in the Diabetic Lancet Device- Market are Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, BIONIME, Yuwell

What are the Application segmentation covered in the Diabetic Lancet Device- Market report?

Ans: The Applications covered in the Diabetic Lancet Device- Market report are Hospitals and Clinics, Household Use

What are the Type segmentation covered in the Diabetic Lancet Device- Market report?

Ans: The Types covered in the Diabetic Lancet Device- Market report are 50 Test Strips, 100 Test Strips, 150 Test Strips, 200 Test Strips

Recommended Reports

Diabetes Devices

Blood Glucose Meters

Blood Sampling & Monitoring

1 Market Overview

1.1 Diabetic Lancet Device Product Introduction

1.2 Global Diabetic Lancet Device Market Size Forecast

1.2.1 Global Diabetic Lancet Device Sales Value (2020-2031)

1.2.2 Global Diabetic Lancet Device Sales Volume (2020-2031)

1.2.3 Global Diabetic Lancet Device Sales Price (2020-2031)

1.3 Diabetic Lancet Device Market Trends & Drivers

1.3.1 Diabetic Lancet Device Industry Trends

1.3.2 Diabetic Lancet Device Market Drivers & Opportunity

1.3.3 Diabetic Lancet Device Market Challenges

1.3.4 Diabetic Lancet Device Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diabetic Lancet Device Players Revenue Ranking (2024)

2.2 Global Diabetic Lancet Device Revenue by Company (2020-2025)

2.3 Global Diabetic Lancet Device Players Sales Volume Ranking (2024)

2.4 Global Diabetic Lancet Device Sales Volume by Company Players (2020-2025)

2.5 Global Diabetic Lancet Device Average Price by Company (2020-2025)

2.6 Key Manufacturers Diabetic Lancet Device Manufacturing Base and Headquarters

2.7 Key Manufacturers Diabetic Lancet Device Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Diabetic Lancet Device

2.9 Diabetic Lancet Device Market Competitive Analysis

2.9.1 Diabetic Lancet Device Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Diabetic Lancet Device Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancet Device as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 50 Test Strips

3.1.2 100 Test Strips

3.1.3 150 Test Strips

3.1.4 200 Test Strips

3.2 Global Diabetic Lancet Device Sales Value by Type

3.2.1 Global Diabetic Lancet Device Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Diabetic Lancet Device Sales Value, by Type (2020-2031)

3.2.3 Global Diabetic Lancet Device Sales Value, by Type (%) (2020-2031)

3.3 Global Diabetic Lancet Device Sales Volume by Type

3.3.1 Global Diabetic Lancet Device Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Diabetic Lancet Device Sales Volume, by Type (2020-2031)

3.3.3 Global Diabetic Lancet Device Sales Volume, by Type (%) (2020-2031)

3.4 Global Diabetic Lancet Device Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals and Clinics

4.1.2 Household Use

4.2 Global Diabetic Lancet Device Sales Value by Application

4.2.1 Global Diabetic Lancet Device Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Diabetic Lancet Device Sales Value, by Application (2020-2031)

4.2.3 Global Diabetic Lancet Device Sales Value, by Application (%) (2020-2031)

4.3 Global Diabetic Lancet Device Sales Volume by Application

4.3.1 Global Diabetic Lancet Device Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Diabetic Lancet Device Sales Volume, by Application (2020-2031)

4.3.3 Global Diabetic Lancet Device Sales Volume, by Application (%) (2020-2031)

4.4 Global Diabetic Lancet Device Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Diabetic Lancet Device Sales Value by Region

5.1.1 Global Diabetic Lancet Device Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Diabetic Lancet Device Sales Value by Region (2020-2025)

5.1.3 Global Diabetic Lancet Device Sales Value by Region (2026-2031)

5.1.4 Global Diabetic Lancet Device Sales Value by Region (%), (2020-2031)

5.2 Global Diabetic Lancet Device Sales Volume by Region

5.2.1 Global Diabetic Lancet Device Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Diabetic Lancet Device Sales Volume by Region (2020-2025)

5.2.3 Global Diabetic Lancet Device Sales Volume by Region (2026-2031)

5.2.4 Global Diabetic Lancet Device Sales Volume by Region (%), (2020-2031)

5.3 Global Diabetic Lancet Device Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Diabetic Lancet Device Sales Value, 2020-2031

5.4.2 North America Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Diabetic Lancet Device Sales Value, 2020-2031

5.5.2 Europe Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Diabetic Lancet Device Sales Value, 2020-2031

5.6.2 Asia Pacific Diabetic Lancet Device Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Diabetic Lancet Device Sales Value, 2020-2031

5.7.2 South America Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Diabetic Lancet Device Sales Value, 2020-2031

5.8.2 Middle East & Africa Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diabetic Lancet Device Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Diabetic Lancet Device Sales Value

6.2.1 Key Countries/Regions Diabetic Lancet Device Sales Value, 2020-2031

6.2.2 Key Countries/Regions Diabetic Lancet Device Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Diabetic Lancet Device Sales Value, 2020-2031

6.3.2 United States Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Diabetic Lancet Device Sales Value, 2020-2031

6.4.2 Europe Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Diabetic Lancet Device Sales Value, 2020-2031

6.5.2 China Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.5.3 China Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Diabetic Lancet Device Sales Value, 2020-2031

6.6.2 Japan Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Diabetic Lancet Device Sales Value, 2020-2031

6.7.2 South Korea Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Diabetic Lancet Device Sales Value, 2020-2031

6.8.2 Southeast Asia Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Diabetic Lancet Device Sales Value, 2020-2031

6.9.2 India Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

6.9.3 India Diabetic Lancet Device Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Roche

7.1.1 Roche Company Information

7.1.2 Roche Introduction and Business Overview

7.1.3 Roche Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Roche Diabetic Lancet Device Product Offerings

7.1.5 Roche Recent Development

7.2 Lifescan

7.2.1 Lifescan Company Information

7.2.2 Lifescan Introduction and Business Overview

7.2.3 Lifescan Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Lifescan Diabetic Lancet Device Product Offerings

7.2.5 Lifescan Recent Development

7.3 Abbott

7.3.1 Abbott Company Information

7.3.2 Abbott Introduction and Business Overview

7.3.3 Abbott Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Abbott Diabetic Lancet Device Product Offerings

7.3.5 Abbott Recent Development

7.4 Ascensia

7.4.1 Ascensia Company Information

7.4.2 Ascensia Introduction and Business Overview

7.4.3 Ascensia Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Ascensia Diabetic Lancet Device Product Offerings

7.4.5 Ascensia Recent Development

7.5 B. Braun

7.5.1 B. Braun Company Information

7.5.2 B. Braun Introduction and Business Overview

7.5.3 B. Braun Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 B. Braun Diabetic Lancet Device Product Offerings

7.5.5 B. Braun Recent Development

7.6 TERUMO

7.6.1 TERUMO Company Information

7.6.2 TERUMO Introduction and Business Overview

7.6.3 TERUMO Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 TERUMO Diabetic Lancet Device Product Offerings

7.6.5 TERUMO Recent Development

7.7 Sinocare

7.7.1 Sinocare Company Information

7.7.2 Sinocare Introduction and Business Overview

7.7.3 Sinocare Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Sinocare Diabetic Lancet Device Product Offerings

7.7.5 Sinocare Recent Development

7.8 ARKRAY

7.8.1 ARKRAY Company Information

7.8.2 ARKRAY Introduction and Business Overview

7.8.3 ARKRAY Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 ARKRAY Diabetic Lancet Device Product Offerings

7.8.5 ARKRAY Recent Development

7.9 BIONIME

7.9.1 BIONIME Company Information

7.9.2 BIONIME Introduction and Business Overview

7.9.3 BIONIME Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 BIONIME Diabetic Lancet Device Product Offerings

7.9.5 BIONIME Recent Development

7.10 Yuwell

7.10.1 Yuwell Company Information

7.10.2 Yuwell Introduction and Business Overview

7.10.3 Yuwell Diabetic Lancet Device Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Yuwell Diabetic Lancet Device Product Offerings

7.10.5 Yuwell Recent Development

8 Industry Chain Analysis

8.1 Diabetic Lancet Device Industrial Chain

8.2 Diabetic Lancet Device Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diabetic Lancet Device Sales Model

8.5.2 Sales Channel

8.5.3 Diabetic Lancet Device Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Roche

LifeScan Inc

Abbott

Ascensia

B. Braun

Terumo

Sinocare

Arkray

Bionime

Yuwell

List of Tables

Table 1. Diabetic Lancet Device Market Trends

Table 2. Diabetic Lancet Device Market Drivers & Opportunity

Table 3. Diabetic Lancet Device Market Challenges

Table 4. Diabetic Lancet Device Market Restraints

Table 5. Global Diabetic Lancet Device Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Diabetic Lancet Device Revenue Market Share by Company (2020-2025)

Table 7. Global Diabetic Lancet Device Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Diabetic Lancet Device Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Diabetic Lancet Device Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Diabetic Lancet Device Manufacturing Base and Headquarters

Table 11. Key Manufacturers Diabetic Lancet Device Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Diabetic Lancet Device

Table 13. Global Diabetic Lancet Device Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancet Device as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Diabetic Lancet Device Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Diabetic Lancet Device Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Diabetic Lancet Device Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Diabetic Lancet Device Sales Market Share in Value by Type (2020-2025)

Table 20. Global Diabetic Lancet Device Sales Market Share in Value by Type (2026-2031)

Table 21. Global Diabetic Lancet Device Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Diabetic Lancet Device Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Diabetic Lancet Device Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Diabetic Lancet Device Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Diabetic Lancet Device Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Diabetic Lancet Device Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Diabetic Lancet Device Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Diabetic Lancet Device Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Diabetic Lancet Device Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Diabetic Lancet Device Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Diabetic Lancet Device Sales Market Share in Value by Application (2020-2025)

Table 32. Global Diabetic Lancet Device Sales Market Share in Value by Application (2026-2031)

Table 33. Global Diabetic Lancet Device Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Diabetic Lancet Device Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Diabetic Lancet Device Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Diabetic Lancet Device Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Diabetic Lancet Device Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Diabetic Lancet Device Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Diabetic Lancet Device Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Diabetic Lancet Device Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Diabetic Lancet Device Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Diabetic Lancet Device Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Diabetic Lancet Device Sales Value by Region (2020-2025) & (%)

Table 44. Global Diabetic Lancet Device Sales Value by Region (2026-2031) & (%)

Table 45. Global Diabetic Lancet Device Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Diabetic Lancet Device Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Diabetic Lancet Device Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Diabetic Lancet Device Sales Volume by Region (2020-2025) & (%)

Table 49. Global Diabetic Lancet Device Sales Volume by Region (2026-2031) & (%)

Table 50. Global Diabetic Lancet Device Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Diabetic Lancet Device Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Diabetic Lancet Device Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Diabetic Lancet Device Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Diabetic Lancet Device Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Diabetic Lancet Device Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Diabetic Lancet Device Sales Volume, (2026-2031) & (K Units)

Table 57. Roche Company Information

Table 58. Roche Introduction and Business Overview

Table 59. Roche Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Roche Diabetic Lancet Device Product Offerings

Table 61. Roche Recent Development

Table 62. Lifescan Company Information

Table 63. Lifescan Introduction and Business Overview

Table 64. Lifescan Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Lifescan Diabetic Lancet Device Product Offerings

Table 66. Lifescan Recent Development

Table 67. Abbott Company Information

Table 68. Abbott Introduction and Business Overview

Table 69. Abbott Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Abbott Diabetic Lancet Device Product Offerings

Table 71. Abbott Recent Development

Table 72. Ascensia Company Information

Table 73. Ascensia Introduction and Business Overview

Table 74. Ascensia Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Ascensia Diabetic Lancet Device Product Offerings

Table 76. Ascensia Recent Development

Table 77. B. Braun Company Information

Table 78. B. Braun Introduction and Business Overview

Table 79. B. Braun Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. B. Braun Diabetic Lancet Device Product Offerings

Table 81. B. Braun Recent Development

Table 82. TERUMO Company Information

Table 83. TERUMO Introduction and Business Overview

Table 84. TERUMO Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. TERUMO Diabetic Lancet Device Product Offerings

Table 86. TERUMO Recent Development

Table 87. Sinocare Company Information

Table 88. Sinocare Introduction and Business Overview

Table 89. Sinocare Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Sinocare Diabetic Lancet Device Product Offerings

Table 91. Sinocare Recent Development

Table 92. ARKRAY Company Information

Table 93. ARKRAY Introduction and Business Overview

Table 94. ARKRAY Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. ARKRAY Diabetic Lancet Device Product Offerings

Table 96. ARKRAY Recent Development

Table 97. BIONIME Company Information

Table 98. BIONIME Introduction and Business Overview

Table 99. BIONIME Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. BIONIME Diabetic Lancet Device Product Offerings

Table 101. BIONIME Recent Development

Table 102. Yuwell Company Information

Table 103. Yuwell Introduction and Business Overview

Table 104. Yuwell Diabetic Lancet Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Yuwell Diabetic Lancet Device Product Offerings

Table 106. Yuwell Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Diabetic Lancet Device Downstream Customers

Table 110. Diabetic Lancet Device Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Diabetic Lancet Device Product Picture

Figure 2. Global Diabetic Lancet Device Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Diabetic Lancet Device Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Diabetic Lancet Device Sales Volume (2020-2031) & (K Units)

Figure 5. Global Diabetic Lancet Device Sales Price (2020-2031) & (US$/Unit)

Figure 6. Diabetic Lancet Device Report Years Considered

Figure 7. Global Diabetic Lancet Device Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Diabetic Lancet Device Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetic Lancet Device Revenue in 2024

Figure 10. Diabetic Lancet Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 50 Test Strips Picture

Figure 12. 100 Test Strips Picture

Figure 13. 150 Test Strips Picture

Figure 14. 200 Test Strips Picture

Figure 15. Global Diabetic Lancet Device Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Diabetic Lancet Device Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Diabetic Lancet Device Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 18. Global Diabetic Lancet Device Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Diabetic Lancet Device Price by Type (2020-2031) & (US$/Unit)

Figure 20. Product Picture of Hospitals and Clinics

Figure 21. Product Picture of Household Use

Figure 22. Global Diabetic Lancet Device Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Diabetic Lancet Device Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Diabetic Lancet Device Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 25. Global Diabetic Lancet Device Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Diabetic Lancet Device Price by Application (2020-2031) & (US$/Unit)

Figure 27. North America Diabetic Lancet Device Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Diabetic Lancet Device Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Diabetic Lancet Device Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Diabetic Lancet Device Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Diabetic Lancet Device Sales Volume (%), (2020-2031)

Figure 39. United States Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 45. China Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 47. China Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 57. India Diabetic Lancet Device Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Diabetic Lancet Device Sales Value by Type (%), 2024 VS 2031

Figure 59. India Diabetic Lancet Device Sales Value by Application (%), 2024 VS 2031

Figure 60. Diabetic Lancet Device Industrial Chain

Figure 61. Diabetic Lancet Device Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Blood Sugar Lancets Market Research Report 2024

Global Lancet Pens and Needles Market Research Report 2024

Global Finger stick Blood Samplers Lancet Devices Market Research Report 2025

Global Disposable Diabetes Lancets Market Research Report 2024

Diabetes Lancing Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Sugar Monitoring Equipment Market Research Report 2025

Global Safety Lancets for Diabetes Market Research Report 2025

Global Blood Glucose Testing Devices Market Research Report 2024

Global Diabetes Lancets for Home Market Research Report 2025

Global Diabetes Monitoring Devices Market Insights Forecast to 2030

Global Blood Micro sampling Medical Devices Market Research Report 2025

Global Blood Glucose Monitoring Lancing Device Market Research Report 2025

Global Micro Blood Sampling Devices Market Research Report 2024

Global Blood Sugar Pen Market Research Report 2025

Global Smart Blood Glucose Monitoring Device Market Research Report 2024

Global Medical Disposable Lancet Market Research Report 2024

Diabetes Blood Collection Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Sampling Weighing Instrument Market Research Report 2024

Global Blood Glucose Meter and Blood Glucose Test Strips Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions